Dr. Schoolderman L. Neuroloog SRL
Dr. Schoolderman L. Neuroloog reported total assets of 175,621 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Dr. Schoolderman L. Neuroloog shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +135 % Total assets +71 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Schoolderman L. Neuroloog's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 27,015 € | ||||
| Equity | 163,811 € | ||||
| Cash | 40,217 € | ||||
| EBITDA | 49,501 € | ||||
| Total assets | 175,621 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 19 Aug 2025
- Year ended 31 Dec 2023filed on 19 Aug 2024
- Year ended 31 Dec 2022filed on 18 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Dr. Schoolderman L. Neuroloog's financial analysis
- Solvency93.3%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Schoolderman L. Neuroloog
Dr. Schoolderman L. Neuroloog's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0642.937.972
- VAT number
- BE0642937972
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 17 Nov 2015
- Registered office
- 3770 Riemst
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Schoolderman L. Neuroloog (SRL) has been based in Riemst since 2015, active in: medical specialists activities. For 2025, it reports a net profit of 27,015 € and equity of 163,811 €; its revenue is not published. Its solvency stands at 93.3%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Schoolderman L. Neuroloog
Companies in the same business, of comparable size and area, outside its group.
- Inverta Manufacture of ceramic tiles and flags Willebroek · balance sheet 175,626 €
- Spittsinvest Business and other management consultancy activities Wemmel · balance sheet 175,565 €
- Business Consulting and Contracting Market research and public opinion polling Rixensart · balance sheet 175,477 €
- Ten Lande Houthulst · balance sheet 175,474 €
Frequently asked questions about Dr. Schoolderman L. Neuroloog
What is the revenue of Dr. Schoolderman L. Neuroloog?
Dr. Schoolderman L. Neuroloog files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Schoolderman L. Neuroloog?
In Belgium, the VAT number is the company number prefixed with BE: BE0642937972 for Dr. Schoolderman L. Neuroloog, if the company is VAT-registered. Its company number (CBE) is 0642.937.972.
Where is the registered office of Dr. Schoolderman L. Neuroloog?
According to the CBE register, the registered office of Dr. Schoolderman L. Neuroloog is in 3770 Riemst.
What is the equity of Dr. Schoolderman L. Neuroloog?
At the close of the 2025 financial year, the equity of Dr. Schoolderman L. Neuroloog amounts to 163,811 €, a solvency of 93.3% of total assets.
Who manages Dr. Schoolderman L. Neuroloog?
The register lists 1 active mandates at Dr. Schoolderman L. Neuroloog. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Schoolderman L. Neuroloog
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →